This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
250mg | $1850 | Check With Us |
500mg | $2850 | Check With Us |
1g | $4275 | Check With Us |
Cat #: V4284 CAS #: 1234423-95-0 Purity ≥ 98%
Description: Tenapanor (formerly RDX-5791; RDX 5791; AZD-1722; AZD1722; trade name Ibsrela) is a first-in-class inhibitor of sodium-hydrogen exchanger (NHE3) approved by FDA in 2019 for the treatment of irritable bowel syndrome with constipation (IBS-C).
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 1145.05 |
---|---|
Molecular Formula | C50H66Cl4N8O10S2 |
CAS No. | 1234423-95-0 |
Storage | -20℃ for 3 years in powder formr |
-80℃ for 2 years in solvent |
Protocol | In Vivo | Tenapanor (0.15 mg/kg; p.o.; twice-daily for 11 consecutive days) increases the reduction in urinary phosphorus excretion in rats |
---|
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 0.8733 mL | 4.3666 mL | 8.7332 mL | 17.4665 mL |
5mM | 0.1747 mL | 0.8733 mL | 1.7466 mL | 3.4933 mL |
10mM | 0.0873 mL | 0.4367 mL | 0.8733 mL | 1.7466 mL |
20mM | 0.0437 mL | 0.2183 mL | 0.4367 mL | 0.8733 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.